Enterobacter cloacae
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
| Ampicillin | 7 |
Imipenem | 99 |
|
| Azithromycin | - |
Levofloxacin | 98 |
|
| Aztreonam | 86 |
Meropenem | 100 |
|
| Cefazolin | 5 |
Moxifloxacin | 93
|
|
| Cefepime | 99 |
Nitrofurantoin | 33
|
|
| Ceftazidime | 87 |
Oxacillin/Naf | - |
|
| Ceftriaxone | 87 |
Penicillin | - |
|
| Cefuroxime | 25 |
Piperacillin | 83
|
|
| Ciprofloxacin | 98 |
Piperacillin/tazo | 85 |
|
| Clarithromycin | - |
Ticarcillin/Clav | 83 |
|
| Clindamycin | - |
Tobramycin | 98 |
|
| Doxycycline | - |
TMP/SMX | 96 |
|
| Erythromycin | - |
Unasyn/Aug | 26 |
|
| Gentamicin | 99 |
Vancomycin | - |
|
Comments:
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections